DAFNA Capital Management’s Century Therapeutics IPSC Stock Holding History

DAFNA Capital Management’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.88M	Sell	2,400,458 -33,895	-1%	-$77.4K	1.12%	22
2026 Q1	$5.5M	Sell	2,434,353 -359,233	-13%	-$755K	1.25%	21
2025 Q4	$2.78M	Buy	2,793,586 +1,089,354	+64%	+$665K	0.65%	38
2025 Q3	$849K	Hold	1,704,232	–	–	0.21%	61
2025 Q2	$952K	Hold	1,704,232	–	–	0.26%	60
2025 Q1	$811K	Hold	1,704,232	–	–	0.23%	64
2024 Q4	$1.72M	Hold	1,704,232	–	–	0.44%	45
2024 Q3	$2.91M	Hold	1,704,232	–	–	0.69%	38
2024 Q2	$4.35M	Buy	1,704,232 +396,825	+30%	+$1.25M	1.04%	28
2024 Q1	$5.46M	Hold	1,307,407	–	–	1.24%	26
2023 Q4	$4.34M	Hold	1,307,407	–	–	1.04%	32
2023 Q3	$2.61M	Hold	1,307,407	–	–	0.81%	33
2023 Q2	$4.13M	Hold	1,307,407	–	–	1.13%	27
2023 Q1	$4.54M	Buy	1,307,407 +832,040	+175%	+$3.65M	1.36%	27
2022 Q4	$2.44M	Hold	475,367	–	–	0.69%	40
2022 Q3	$4.7M	Hold	475,367	–	–	1.26%	26
2022 Q2	$3.99M	Buy	475,367 +218,475	+85%	+$2.14M	1.09%	29
2022 Q1	$3.23M	Buy	256,892 +156,757	+157%	+$2.08M	0.84%	33
2021 Q4	$1.59M	Buy	100,135 +20,135	+25%	+$378K	0.4%	50
2021 Q3	$2.01M	Hold	80,000	–	–	0.53%	46
2021 Q2	$2.35M	Buy	+80,000	New	+$2.03M	0.49%	44

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

DAFNA Capital Management's IPSC Position: Q2 2026 in Review

DAFNA Capital Management reduced its Century Therapeutics (IPSC) stake by 1.4% in Q2 2026, selling an estimated $77.4K and leaving 2,400,458 shares worth $5.88M. The position accounts for 1.12% of the portfolio, ranked #22.

DAFNA Capital Management first reported a position in IPSC in Q2 2021 and has held it in 21 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

DAFNA Capital Management held 2,400,458 shares of Century Therapeutics worth $5.88M as of Q2 2026.
DAFNA Capital Management sold 33,895 Century Therapeutics shares in Q2 2026, an estimated $77.4K.
Century Therapeutics made up 1.12% of DAFNA Capital Management's portfolio in Q2 2026, its #22 holding.
DAFNA Capital Management first reported a position in Century Therapeutics in Q2 2021 and has held it in 21 quarters since.
99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on DAFNA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.